Ultragenyx Pharmaceutical (RARE) Intangibles (2017 - 2026)
Ultragenyx Pharmaceutical's Intangibles came in at $172 million for Q2 2026, down 1.6% from $174.73 million a year earlier and down 1.1% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Intangibles (2017 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Intangibles was $176 million, down 1.1% from FY2024.
- Intangibles carries a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- Going back by year, Intangibles was $178 million in FY2024 (+7.1%), $166.27 million in FY2023 (+3.9%), $160.11 million in FY2022 (+22.4%) and $130.79 million in FY2021 (-0.2%).
- The Q2 2026 figure represents the lowest quarterly Intangibles since Q3 2024.
- Year-over-year, Intangibles has declined for three consecutive quarters, with growth averaging 3.1% over the last eight quarters.
- The fastest year-over-year change in Intangibles over five years came in Q4 2022 (growth of 22.4%), and the weakest in Q2 2026 (a decline of 1.6%).
- Business Quant data shows RARE's Intangibles at $174 million (Q1 2026), $176 million (Q4 2025) and $172.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 172.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172.00 Mn |
| Mar 31, 2026 | 174.00 Mn |
| Dec 31, 2025 | 176.00 Mn |
| Sep 30, 2025 | 172.94 Mn |
| Jun 30, 2025 | 174.73 Mn |
| Mar 31, 2025 | 176.52 Mn |
| Dec 31, 2024 | 178.00 Mn |
| Sep 30, 2024 | 164.94 Mn |
| Jun 30, 2024 | 166.24 Mn |
| Mar 31, 2024 | 165.05 Mn |
| Dec 31, 2023 | 166.27 Mn |
| Sep 30, 2023 | 157.30 Mn |
| Jun 30, 2023 | 158.24 Mn |
| Mar 31, 2023 | 159.17 Mn |
| Dec 31, 2022 | 160.11 Mn |
| Sep 30, 2022 | 158.40 Mn |
| Jun 30, 2022 | 159.20 Mn |
| Mar 31, 2022 | 159.99 Mn |
| Dec 31, 2021 | 130.79 Mn |
| Sep 30, 2021 | 130.87 Mn |
API Access
Ultragenyx Pharmaceutical Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();